John R. Yates is the Ernest W. Hahn Professor in the Departments of Molecular Medicine and Neurobiology at The Scripps Research Institute. His research interests include development of integrated methods for tandem mass spectrometry analysis of protein mixtures, bioinformatics…

Dr. Webb is currently CEO of Synbal(www.synbal.com), Chairman of the Board at Agragene (www.agragene/com)and Adjunct Professor at The Scripps Research Institute (TSRI).  He was Chairman of the Board of Sorrento Therapeutics from 2012-2014and is also former chairman of the…

Greg Reyes, M.D., Ph.D. has over 30 years of experience as a senior leader in biotech and large pharma exploring drug discovery and development in multiple therapy areas.   His leadership positions included leading Drug Discovery for Celgene Corporation and…

Dr. Chapman is a veteran of large and small biotech companies.  He is well versed in all aspects of drug discovery, from target selection, validation, screening, hit-to-lead, lead optimization, preclinical testing, candidate selection, and early clinical development. He has worked…

Mike Breider, D.V.M., Ph.D. is a Board Certified Veterinary Pathologist with extensive experience as a manager and scientist in various aspects of Drug Discovery and Development.  Recently retired, Mike’s last position was with Celgene Pharmaceuticals as the Head of Exploratory Toxicology…